Ken Fisher's ACAD Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 638.5K shares of ACADIA Pharmaceuticals Inc. (ACAD) worth $13.63 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Ken Fisher has maintained this position in ACAD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 328.2K shares. Largest reduction occurred in Q2 2025, reducing 44.7K shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's ACADIA Pharmaceuticals (ACAD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ACADIA Pharmaceuticals (ACAD) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2023 | +143,054 | New Buy | 143,054 | $31.31 |
| Q1 2024 | +9,876 | Add 6.90% | 152,930 | $18.49 |
| Q2 2024 | +9,689 | Add 6.34% | 162,619 | $16.25 |
| Q3 2024 | +31,980 | Add 19.67% | 194,599 | $15.38 |
| Q4 2024 | +132,906 | Add 68.30% | 327,505 | $18.35 |
| Q1 2025 | +27,516 | Add 8.40% | 355,021 | $16.61 |
| Q2 2025 | -44,710 | Reduce 12.59% | 310,311 | $21.57 |
| Q3 2025 | +328,181 | Add 105.76% | 638,492 | $21.34 |
Ken Fisher's ACADIA Pharmaceuticals Investment FAQs
Ken Fisher first purchased ACADIA Pharmaceuticals Inc. (ACAD) in Q4 2023, acquiring 143,054 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held ACADIA Pharmaceuticals Inc. (ACAD) for 8 quarters since Q4 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to ACADIA Pharmaceuticals Inc. (ACAD) was in Q3 2025, adding 638,492 shares worth $13.63 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 638,492 shares of ACADIA Pharmaceuticals Inc. (ACAD), valued at approximately $13.63 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ACADIA Pharmaceuticals Inc. (ACAD) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in ACADIA Pharmaceuticals Inc. (ACAD) was 638,492 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.